Your browser doesn't support javascript.
loading
Ixekizumab provides superior efficacy compared with ustekinumab over 52 weeks of treatment: Results from IXORA-S, a phase 3 study.
Paul, Carle; Griffiths, Christopher E M; van de Kerkhof, Peter C M; Puig, Lluís; Dutronc, Yves; Henneges, Carsten; Dossenbach, Martin; Hollister, Kristin; Reich, Kristian.
Afiliação
  • Paul C; Dermatology Department, CHU, Paul Sabatier University, Toulouse, France. Electronic address: paul.c@chu-toulouse.fr.
  • Griffiths CEM; Dermatology Centre, Salford Royal Hospital, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom.
  • van de Kerkhof PCM; Department of Dermatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
  • Puig L; Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Dutronc Y; Eli Lilly and Company, Indianapolis, Indiana.
  • Henneges C; Eli Lilly and Company, Indianapolis, Indiana.
  • Dossenbach M; Eli Lilly and Company, Indianapolis, Indiana.
  • Hollister K; Eli Lilly and Company, Indianapolis, Indiana.
  • Reich K; Dermatologikum Berlin and Georg-August-University Göttingen, Göttingen, Germany.
J Am Acad Dermatol ; 80(1): 70-79.e3, 2019 Jan.
Article em En | MEDLINE | ID: mdl-29969700
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Fármacos Dermatológicos / Anticorpos Monoclonais Humanizados / Ustekinumab Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Fármacos Dermatológicos / Anticorpos Monoclonais Humanizados / Ustekinumab Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2019 Tipo de documento: Article